Hi folks, hoping for help with a difficult decision. I am caregiver for someone who, on diagnosis five years ago, was found to have bone lesions throughout the torso from pelvis to skull. Also lymph node involvement, but no organ involvement.
Treatment over the last five years has pretty much knocked it out of the lymph nodes, although he has had some spread of lesions in the skeletal system.
His PSA at diagnosis was over 1500. It got down to .01. It is still below 1 but the Zytiga that kept it at bay for 2 1/2 years failed. He tried a trial and Lynparza, but they both failed. He’s now on Xtandi, which is working, but we know it’s a parallel drug to Zytiga and will likely fail fairly quickly.
The dilemma is our next step. I was leaning toward Jevtana. His oncologist wants to try AMG 160. This is the BiTE trial at Emory Winship. He would either get just the AMG 160 or AMG 160 with Keytruda (pembrolizumab.)
I’ve heard of pretty severe side effects from AMG 160. Also, it involves hospitalization three times in the first month. But I’m also very enthusiastic about immuno therapy‘s as a treatment for cancer. But Pat is very weak from his three months on Lynparza, which left him hospitalized. He’s still recovering almost 3 months later.
Any Suggestions on which path we should take? I know people will say talk to your oncologist, but unfortunately ours is not that type of doctor. Yes we should change doctors. But until now it’s been the standard of care so it hasn’t been difficult. I’d like to change doctors at this point but Pat is reluctant to change horses midstream. I understand the fear.
So I’m trying to find people that have had Jevtana or been in this AMG 160 trial to get a feel for which way we should go.
Thanks for any help anyone can provide.